Market revenue in 2023 | USD 90.0 million |
Market revenue in 2030 | USD 142.9 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.44% in 2023. Horizon Databook has segmented the Thailand diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Rising incidence of diabetes and related injuries are major driving factors for the market. For instance, as per International Diabetes Federation in 2019, the prevalence of diabetes in adults was around 8.3% in Thailand in 2017.
Increasing healthcare expenditure in Thailand may also encourage major market players to enter the market, which is expected to grow significantly over the forecast period. The domestic consumption of medical devices is high in Thailand.
This is due to the growth of medical services. Advanced wound care products, such as wound dressings, are imported. Moreover, market players operating in Thailand are entering into agreements, such as acquisition of assets and product launches. For instance, in June 2022, Selic Corp Public Company Limited agreed to buy the rights to Neoplast & Neoburn and related assets from 3M.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Thailand diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account